Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.
暂无分享,去创建一个
Richard D Moore | O. Platt | E. Orringer | S. Eckert | G. Dover | S. Charache | R. Moore | P. Milner | M. Koshy | G. Phillips | R D Moore | G J Dover | P. Milner | S Charache | S. Ballas | S Eckert | G Phillips | M Koshy | S K Ballas | E P Orringer | O S Platt | P F Milner | OS Platt
[1] S. Greenfield,et al. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. , 1989, JAMA.
[2] J. G. Cory,et al. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit. , 1984, Advances in enzyme regulation.
[3] E Vichinsky,et al. Pain in sickle cell disease. Rates and risk factors. , 1991, The New England journal of medicine.
[4] G. Dover,et al. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo , 1989, American journal of hematology.
[5] B. Alter,et al. The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromes. , 1985, Blood.
[6] B. Kennedy,et al. Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia. , 1965, Transactions of the Association of American Physicians.
[7] R. Edalji,et al. Oxygen affinity as an index of hemoglobin S polymerization: a new micromethod. , 1978, Analytical biochemistry.
[8] John T. Wilson,et al. The effect of Hb F and α‐thalassemia on the red cell indices in sickle cell anemia , 1986 .
[9] A. Schechter,et al. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. , 1990, The New England journal of medicine.
[10] Edward B. Perrin,et al. The Medical Outcomes Study. An application of methods for monitoring the results of medical care , 1989 .
[11] K. Betke,et al. Estimation of Small Percentages of Fœtal Hæmoglobin , 1959, Nature.
[12] George J. Dover,et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia [see comments] , 1992 .
[13] G. Dover,et al. Fetal hemoglobin-containing cells have the same mean corpuscular hemoglobin as cells without fetal hemoglobin: a reciprocal relationship between gamma- and beta-globin gene expression in normal subjects and in those with high fetal hemoglobin production. , 1987, Blood.
[14] J. England,et al. The Determinants of Irreversibly Sickled Cells in Homozygous Sickle Cell Disease , 1978, British journal of haematology.
[15] R. Painter,et al. Effect of caffeine on DNA synthesis in irradiated and unirradiated mammalian cells. , 1980, Journal of molecular biology.
[16] W. Bell,et al. Microscopic method for assaying F cell production: illustrative changes during infancy and in aplastic anemia. , 1978, Blood.
[17] O. Akinyanju,et al. Leg ulceration in sickle cell disease in Nigeria. , 1979, Tropical and geographical medicine.
[18] E. Fabricius,et al. Determination of hydroxyurea in mammalian tissues and blood. , 1971, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.
[19] T. Huisman,et al. DNA sequence variation associated with elevated fetal G gamma globin production. , 1985, Blood.
[20] K. Betke,et al. Estimation of small percentages of foetal haemoglobin. , 1959, Nature.
[21] J. Bertles,et al. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia. , 1968, The Journal of clinical investigation.
[22] S. Antonarakis,et al. Origin of the beta S-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. K. Srivastava,et al. Aspirin blocks 5-azacytidine- and hydroxyurea-induced changes in hemoglobin proportions in adult rats. , 1991, European journal of pharmacology.
[24] G. Dover,et al. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. , 1987, Blood.
[25] T. Ley,et al. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. , 1986, Blood.
[26] S. S. Smith,et al. The tumorigenicity of 5-azacytidine in the male Fischer rat. , 1984, Carcinogenesis.
[27] G. Stamatoyannopoulos,et al. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. , 1985, The New England journal of medicine.
[28] J. Goldberg,et al. Long-term management of polycythemia vera with hydroxyurea: a progress report. , 1986, Seminars in hematology.
[29] D. Zwiers,et al. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Schechter,et al. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. , 1988, The New England journal of medicine.
[31] D. Weatherall,et al. Hereditary persistence of fetal hemoglobin: a study of 79 affected persons in 15 Negro families in Baltimore. , 1963, Blood.
[32] R E Gaines Das,et al. Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. , 1987, Journal of immunological methods.
[33] A. Schechter,et al. Cell heterogeneity in sickle cell disease: quantitation of the erythrocyte density profile. , 1985, The Journal of laboratory and clinical medicine.
[34] Kennedy Bj,et al. Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia. , 1965 .
[35] R S Woodward,et al. The effect of prescribed daily dose frequency on patient medication compliance. , 1990, Archives of internal medicine.
[36] B. Wenz,et al. Volumetric erythrocyte macrocytosis induced by hydroxyurea. , 1986, American journal of clinical pathology.
[37] M. Goldberg,et al. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. , 1990, The New England journal of medicine.
[38] G. Birgegard,et al. Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation , 1989, British journal of haematology.
[39] K. McIntyre,et al. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. , 1984, The New England journal of medicine.
[40] G. Rudali,et al. Comparative study of carcinogenic activity of hydroxyurea and urethane in XVII-G mice. , 1972, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.
[41] G. Stamatoyannopoulos,et al. Erythropoietin stimulates F-reticulocyte formation in sickle cell anemia. , 1988, Transactions of the Association of American Physicians.
[42] D H Tycko,et al. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. , 1986, Blood.
[43] S. Charache,et al. Flow cytometric reticulocyte counting with thioflavin T in a clinical hematology laboratory. , 1987, Archives of pathology & laboratory medicine.